Boehringer Ingelheim

Boehringer Ingelheim is one of the world’s largest family-owned pharmaceutical companies, founded in 1885 in Germany. With a strong focus on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing, the company is a global leader in research-driven innovation. Boehringer Ingelheim is recognized for its therapies in respiratory diseases, cardiovascular conditions, oncology, immunology, diabetes, and central nervous system disorders, as well as its vaccines and treatments for animals.

Mission and Vision

Mission: To transform lives for generations by developing innovative medicines that address unmet medical needs for humans and animals.
Vision: To create value through innovation in healthcare, improving lives and contributing to a sustainable future.

Products and Services

Human Pharmaceuticals: Jardiance (diabetes & heart failure), Spiriva (respiratory), Ofev (pulmonary fibrosis), and a growing oncology portfolio.
Animal Health: Medicines and vaccines for livestock and pets, including NexGard (parasite protection).
Biopharmaceuticals: Contract manufacturing for other pharmaceutical companies.
Research & Development: Strong pipeline in immunology, oncology, and regenerative medicine.

Growth and Innovation
As a privately held company, Boehringer Ingelheim reinvests a large portion of its profits into R&D, focusing on breakthrough therapies in oncology, fibrosis, and precision medicine. Its diabetes drug Jardiance, co-developed with Eli Lilly, has become a blockbuster. The company is also expanding into digital health, cell therapy, and regenerative approaches, while its animal health division is one of the largest in the world.

Global Impact
Boehringer Ingelheim operates in more than 130 markets and employs tens of thousands worldwide. Its dual focus on human and animal health enables it to impact both patient care and food security. The company is committed to sustainability, aiming for carbon neutrality and improved access to medicines in low- and middle-income countries.